XML 38 R27.htm IDEA: XBRL DOCUMENT
v3.25.2

STOCKHOLDERS' EQUITY (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Equity [Abstract] |
Schedule of Stockholders Equity | The following tables present the changes in stockholders’ equity (in millions):
| Three Months Ended June 30, 2025
| Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Total Intuitive Surgical, Inc. Stockholders’ Equity |  | Noncontrolling Interest in Joint Venture |  | Total Stockholders’ Equity
| Shares |  | Amount |  |  |  |  |  |
Beginning balance | 358.4 |  |  | $ | 0.4 |  |  | $ | 9,993.7 |  |  | $ | 7,139.4 |  |  | $ | (27.1) |  |  | $ | 17,106.4 |  |  | $ | 101.3 |  |  | $ | 17,207.7 |
Issuance of common stock through employee stock plans | 0.4 |  |  | — |  |  | 49.4 |  |  | — |  |  | — |  |  | 49.4 |  |  | — |  |  | 49.4 |
Shares withheld related to net share settlement of equity awards | (0.1) |  |  | — |  |  | (0.4) |  |  | (15.8) |  |  | — |  |  | (16.2) |  |  | — |  |  | (16.2) |
Share-based compensation expense related to employee stock plans | — |  |  | — |  |  | 198.6 |  |  | — |  |  | — |  |  | 198.6 |  |  | — |  |  | 198.6 |
Repurchase and retirement of common stock | (0.3) |  |  | — |  |  | (4.5) |  |  | (176.5) |  |  | — |  |  | (181.0) |  |  | — |  |  | (181.0) |
Net income attributable to Intuitive Surgical, Inc. | — |  |  | — |  |  | — |  |  | 658.4 |  |  | — |  |  | 658.4 |  |  | — |  |  | 658.4 |
Other comprehensive income | — |  |  | — |  |  | — |  |  | — |  |  | 30.1 |  |  | 30.1 |  |  | 0.3 |  |  | 30.4 |
Net income attributable to noncontrolling interest in joint venture | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 5.8 |  |  | 5.8 |
Ending balance | 358.4 |  |  | $ | 0.4 |  |  | $ | 10,236.8 |  |  | $ | 7,605.5 |  |  | $ | 3.0 |  |  | $ | 17,845.7 |  |  | $ | 107.4 |  |  | $ | 17,953.1 |
| Three Months Ended June 30, 2024
| Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Total Intuitive Surgical, Inc. Stockholders’ Equity |  | Noncontrolling Interest in Joint Venture |  | Total Stockholders’ Equity
| Shares |  | Amount |  |  |  |  |  |
Beginning balance | 354.7 |  |  | $ | 0.4 |  |  | $ | 8,903.0 |  |  | $ | 5,067.9 |  |  | $ | (8.7) |  |  | $ | 13,962.6 |  |  | $ | 83.8 |  |  | $ | 14,046.4 |
Issuance of common stock through employee stock plans | 0.6 |  |  | — |  |  | 71.5 |  |  | — |  |  | — |  |  | 71.5 |  |  | — |  |  | 71.5 |
Shares withheld related to net share settlement of equity awards | — |  |  | — |  |  | (0.4) |  |  | (13.1) |  |  | — |  |  | (13.5) |  |  | — |  |  | (13.5) |
Share-based compensation expense related to employee stock plans | — |  |  | — |  |  | 175.6 |  |  | — |  |  | — |  |  | 175.6 |  |  | — |  |  | 175.6 |
Net income attributable to Intuitive Surgical, Inc. | — |  |  | — |  |  | — |  |  | 526.9 |  |  | — |  |  | 526.9 |  |  | — |  |  | 526.9 |
Other comprehensive income (loss) | — |  |  | — |  |  | — |  |  | — |  |  | (14.8) |  |  | (14.8) |  |  | (0.2) |  |  | (15.0) |
Net income attributable to noncontrolling interest in joint venture | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 4.6 |  |  | 4.6 |
Ending balance | 355.3 |  |  | $ | 0.4 |  |  | $ | 9,149.7 |  |  | $ | 5,581.7 |  |  | $ | (23.5) |  |  | $ | 14,708.3 |  |  | $ | 88.2 |  |  | $ | 14,796.5 |
| Six Months Ended June 30, 2025
| Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Total Intuitive Surgical, Inc. Stockholders’ Equity |  | Noncontrolling Interest in Joint Venture |  | Total Stockholders’ Equity
| Shares |  | Amount |  |  |  |  |  |
Beginning balance | 356.6 |  |  | $ | 0.4 |  |  | $ | 9,681.3 |  |  | $ | 6,803.3 |  |  | $ | (51.3) |  |  | $ | 16,433.7 |  |  | $ | 95.9 |  |  | $ | 16,529.6 |
Issuance of common stock through employee stock plans | 2.8 |  |  | — |  |  | 183.7 |  |  | — |  |  | — |  |  | 183.7 |  |  | — |  |  | 183.7 |
Shares withheld related to net share settlement of equity awards | (0.7) |  |  | — |  |  | (8.2) |  |  | (378.1) |  |  | — |  |  | (386.3) |  |  | — |  |  | (386.3) |
Share-based compensation expense related to employee stock plans | — |  |  | — |  |  | 384.5 |  |  | — |  |  | — |  |  | 384.5 |  |  | — |  |  | 384.5 |
Repurchase and retirement of common stock | (0.3) |  |  | — |  |  | (4.5) |  |  | (176.5) |  |  | — |  |  | (181.0) |  |  | — |  |  | (181.0) |
Net income attributable to Intuitive Surgical, Inc. | — |  |  | — |  |  | — |  |  | 1,356.8 |  |  | — |  |  | 1,356.8 |  |  | — |  |  | 1,356.8 |
Other comprehensive income | — |  |  | — |  |  | — |  |  | — |  |  | 54.3 |  |  | 54.3 |  |  | 0.4 |  |  | 54.7 |
Net income attributable to noncontrolling interest in joint venture | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 11.1 |  |  | 11.1 |
Ending balance | 358.4 |  |  | $ | 0.4 |  |  | $ | 10,236.8 |  |  | $ | 7,605.5 |  |  | $ | 3.0 |  |  | $ | 17,845.7 |  |  | $ | 107.4 |  |  | $ | 17,953.1 |
| Six Months Ended June 30, 2024
| Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Total Intuitive Surgical, Inc. Stockholders’ Equity |  | Noncontrolling Interest in Joint Venture |  | Total Stockholders’ Equity
| Shares |  | Amount |  |  |  |  |  |
Beginning balance | 352.3 |  |  | $ | 0.4 |  |  | $ | 8,576.4 |  |  | $ | 4,743.0 |  |  | $ | (12.2) |  |  | $ | 13,307.6 |  |  | $ | 89.7 |  |  | $ | 13,397.3 |
Issuance of common stock through employee stock plans | 3.6 |  |  | — |  |  | 251.9 |  |  | — |  |  | — |  |  | 251.9 |  |  | — |  |  | 251.9 |
Shares withheld related to net share settlement of equity awards | (0.6) |  |  | — |  |  | (7.0) |  |  | (233.1) |  |  | — |  |  | (240.1) |  |  | — |  |  | (240.1) |
Share-based compensation expense related to employee stock plans | — |  |  | — |  |  | 328.4 |  |  | — |  |  | — |  |  | 328.4 |  |  | — |  |  | 328.4 |
Net income attributable to Intuitive Surgical, Inc. | — |  |  | — |  |  | — |  |  | 1,071.8 |  |  | — |  |  | 1,071.8 |  |  | — |  |  | 1,071.8 |
Other comprehensive income (loss) | — |  |  | — |  |  | — |  |  | — |  |  | (11.3) |  |  | (11.3) |  |  | (0.6) |  |  | (11.9) |
Cash dividends declared and paid by joint venture | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (8.0) |  |  | (8.0) |
Net income attributable to noncontrolling interest in joint venture | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 7.1 |  |  | 7.1 |
Ending balance | 355.3 |  |  | $ | 0.4 |  |  | $ | 9,149.7 |  |  | $ | 5,581.7 |  |  | $ | (23.5) |  |  | $ | 14,708.3 |  |  | $ | 88.2 |  |  | $ | 14,796.5 |
Components of Accumulated Other Comprehensive Income, Net of Tax | The components of accumulated other comprehensive income (loss), net of tax, attributable to Intuitive Surgical, Inc. are as follows (in millions):
| Three Months Ended June 30, 2025
| Gains (Losses) on Hedge Instruments |  | Unrealized Gains on Available-for-Sale Securities |  | Foreign Currency Translation Gains (Losses) |  | Employee Benefit Plans |  | Total
Beginning balance | $ | 0.6 |  |  | $ | 14.5 |  |  | $ | (27.7) |  |  | $ | (14.5) |  |  | $ | (27.1) |
Other comprehensive income (loss) before reclassifications | (11.8) |  |  | 7.1 |  |  | 37.8 |  |  | — |  |  | 33.1 |
Amounts reclassified from accumulated other comprehensive income (loss) | (3.5) |  |  | 0.3 |  |  | — |  |  | 0.2 |  |  | (3.0) |
Net current-period other comprehensive income (loss) | (15.3) |  |  | 7.4 |  |  | 37.8 |  |  | 0.2 |  |  | 30.1 |
Ending balance | $ | (14.7) |  |  | $ | 21.9 |  |  | $ | 10.1 |  |  | $ | (14.3) |  |  | $ | 3.0 |
| Three Months Ended June 30, 2024
| Gains on Hedge Instruments |  | Unrealized Losses on Available-for-Sale Securities |  | Foreign Currency Translation Gains (Losses) |  | Employee Benefit Plans |  | Total
Beginning balance | $ | 3.1 |  |  | $ | (33.9) |  |  | $ | 21.6 |  |  | $ | 0.5 |  |  | $ | (8.7) |
Other comprehensive income (loss) before reclassifications | 1.1 |  |  | 5.4 |  |  | (25.1) |  |  | — |  |  | (18.6) |
Amounts reclassified from accumulated other comprehensive income | 3.7 |  |  | 0.1 |  |  | — |  |  | — |  |  | 3.8 |
Net current-period other comprehensive income (loss) | 4.8 |  |  | 5.5 |  |  | (25.1) |  |  | — |  |  | (14.8) |
Ending balance | $ | 7.9 |  |  | $ | (28.4) |  |  | $ | (3.5) |  |  | $ | 0.5 |  |  | $ | (23.5) |
| Six Months Ended June 30, 2025
| Gains (Losses) on Hedge Instruments |  | Unrealized Gains (Losses) on Available-for-Sale Securities |  | Foreign Currency Translation Gains (Losses) |  | Employee Benefit Plans |  | Total
Beginning balance | $ | 11.0 |  |  | $ | (14.6) |  |  | $ | (33.1) |  |  | $ | (14.6) |  |  | $ | (51.3) |
Other comprehensive income (loss) before reclassifications | (27.8) |  |  | 36.2 |  |  | 43.2 |  |  | — |  |  | 51.6 |
Amounts reclassified from accumulated other comprehensive income | 2.1 |  |  | 0.3 |  |  | — |  |  | 0.3 |  |  | 2.7 |
Net current-period other comprehensive income (loss) | (25.7) |  |  | 36.5 |  |  | 43.2 |  |  | 0.3 |  |  | 54.3 |
Ending balance | $ | (14.7) |  |  | $ | 21.9 |  |  | $ | 10.1 |  |  | $ | (14.3) |  |  | $ | 3.0 |
| Six Months Ended June 30, 2024
| Gains (Losses) on Hedge Instruments |  | Unrealized Losses on Available-for-Sale Securities |  | Foreign Currency Translation Gains (Losses) |  | Employee Benefit Plans |  | Total
Beginning balance | $ | (2.5) |  |  | $ | (29.7) |  |  | $ | 19.4 |  |  | $ | 0.6 |  |  | $ | (12.2) |
Other comprehensive income (loss) before reclassifications | 5.2 |  |  | 1.1 |  |  | (22.9) |  |  | — |  |  | (16.6) |
Amounts reclassified from accumulated other comprehensive income (loss) | 5.2 |  |  | 0.2 |  |  | — |  |  | (0.1) |  |  | 5.3 |
Net current-period other comprehensive income (loss) | 10.4 |  |  | 1.3 |  |  | (22.9) |  |  | (0.1) |  |  | (11.3) |
Ending balance | $ | 7.9 |  |  | $ | (28.4) |  |  | $ | (3.5) |  |  | $ | 0.5 |  |  | $ | (23.5) |
Schedule Of Common Stock Repurchased | The following table summarizes stock repurchase activities (in millions, except per share amounts):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Shares repurchased | 0.3 |  |  | — |  |  | 0.3 |  |  | — |
Average price per share | $ | 517.7 |  |  | $ | — |  |  | $ | 517.7 |  |  | $ | — |
Value of shares repurchased | $ | 181.0 |  |  | $ | — |  |  | $ | 181.0 |  |  | $ | — |

X
- Definition Schedule Of Common Stock Repurchased + References No definition available. + Details
Name: | isrg_ScheduleOfCommonStockRepurchasedTableTextBlock
Namespace Prefix: | isrg_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accumulated other comprehensive income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration